1. |
Schuurman MS, van Den Einden LC, Massuger LF, et al. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma[J]. Eur J Cancer, 2013, 49(18):3872-3880.
|
2. |
Höckel M, Schmidt K, Bornmann K, et al. Vulvar field resection:novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy[J]. Gynecol Oncol, 2010, 119(1):106-113.
|
3. |
Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization[J]. Biochim Biophys Acta, 2009, 1796(2):114-128.
|
4. |
Mitra S, Mazumder Indra D, Basu PS, et al. Alterations of RASSF1A in premalignant cervical lesions:clinical and prognostic significance[J]. Mol Carcinog, 2012, 51(9):723-733.
|
5. |
Maliukova AV, Loginov VI, Khodyrev DS, et al. Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors[J]. Mol Biol (Mosk), 2004, 38(6):1005-1013.
|
6. |
南芳芳, 姜洁, 夏敏, 等. RASSF1A基因在子宫内膜癌组织中的表达及意义[J]. 山东大学学报·医学版, 2007, 45(1):94-96, 100.
|
7. |
Fiolka R, Zubor P, Janusicova V, et al. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer[J]. Oncol Rep, 2013, 30(6):2878-2886.
|
8. |
Shi H, Li Y, Wang X, et al. Association between RASSF1A promoter methylation and ovarian cancer:a meta-analysis[J]. PLoS One, 2013, 8(10):e76787.
|
9. |
Zhang Q, Hu G, Yang Q, et al. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA[J]. Gynecol Oncol, 2013, 130(1):132-139.
|
10. |
Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3[J]. Nat Genet, 2000, 25(3):315-319.
|
11. |
Knudson AG. Hereditary cancer:two hits revisited[J]. J Cancer Res Clin Oncol, 1996, 122(3):135-140.
|
12. |
Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours[J]. Oncogene, 2001, 20(12):1509-1518.
|
13. |
沈亮, 张师前. RASSF1A基因甲基化与妇科肿瘤[J]. 国际肿瘤学杂志, 2008, 35(8):621-624.
|
14. |
董延磊, 张师前. RASSF1A基因甲基化与妇科肿瘤发生发展的关系研究进展[J]. 山东医药, 2010, 50(26):111-112.
|
15. |
Vos MD, Ellis CA, Bell A, et al. Ras uses the novel tumor suppressor RASSF1A as an effector to mediate apoptosis[J]. J Biol Chem, 2000, 275(46):35669-35672.
|
16. |
Kim JH, Choi YD, Lee JS, et al. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens[J]. Virchows Arch, 2010, 457(1):35-42.
|
17. |
Christman JK. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation:mechanistic studies and their implications for cancer therapy[J]. Oncogene, 2002, 21(35):5483-5495.
|
18. |
Steiner M, Clark B, Tang JZ, et al. 14-3-3σ mediates G2-M arrest produced by 5-aza-2'-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells[J]. Gynecol Oncol, 2012, 127(1):231-240.
|